Stock Earnings

Question 1

Nanovibronix Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Nanovibronix Inc'in toplam varlıkları $3 olup, net loss $-3'dir.

Question 2

NAOV'ün temel finansal oranları nelerdir?

Accepted Answer

Nanovibronix Inc'in cari oranı 1, net kâr marjı -150, hisse başına satış $74.07'dir.

Question 3

Nanovibronix Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Nanovibronix Inc largest revenue segment is Noninvasive Biological Response-activating Devices, at a revenue of 2,283,000 in the most earnings release.For geography, United States is the primary market for Nanovibronix Inc, at a revenue of 2,162,000.

Question 4

Nanovibronix Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Nanovibronix Inc'in net loss $-3'dir.

Question 5

Nanovibronix Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Nanovibronix Inc'in yükümlülüğü 3'dir.

Question 6

Nanovibronix Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Nanovibronix Inc'in toplam tedavüldeki hisse sayısı 0.03'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	2	2	2	0	1	0
Revenue Growth (YoY)	-33%	0%	--	-100%	--	--
Cost of Revenue	1	1	0	0	0	0
Gross Profit	0	1	1	0	0	0
Selling, General & Admin	6	4	4	4	6	4
Research & Development	2	0	0	0	0	0
Operating Expenses	8	5	4	5	6	4
Other Non Operating Income (Expenses)	--	--	--	0	-1	--
Pretax Income	-8	-3	-3	-5	-14	-4
Income Tax Expense	0	0	0	0	0	0
Net Income	-5	-3	-3	-5	-14	-4
Net Income Growth	150%	0%	-40%	-64%	250%	-20%
Shares Outstanding (Diluted)	0.48	0.02	0.01	0.01	0.01	0
Shares Change (YoY)	1,814.99%	70%	23%	13%	143%	147%
EPS (Diluted)	-11.19	-137.32	-233.24	-422.15	-1,248.25	-925.21
EPS Growth	-90%	-41%	-45%	-66%	35%	-69%
Free Cash Flow	-6	-2	-3	-7	-4	-3
Free Cash Flow Per Share	-12.38	-74.07	-188.67	-542.63	-350.87	-638.29
Gross Margin	0%	50%	50%	0%	0%	0%
Operating Margin	-400%	-150%	-150%	0%	-500%	0%
Profit Margin	-250%	-150%	-150%	0%	-1,400%	0%
Free Cash Flow Margin	-300%	-100%	-150%	0%	-400%	0%
EBITDA	-8	-3	-3	-5	-5	-4
EBITDA Margin	-400%	-150%	-150%	0%	-500%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-8	-3	-3	-5	-5	-4
EBIT Margin	-400%	-150%	-150%	0%	-500%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Nanovibronix Inc (NAOV) Price

NAOV Stock Price Chart

NAOV Income

Follow-Up Questions